Is LBPH or GBDC a better dividend investment in 2026?

LBPH currently yields 3.33% with a 5% 5-year dividend growth rate. GBDC yields 11.86% with 5% growth. The better choice depends on your goal: GBDC offers higher current income.

What is the dividend yield difference between LBPH and GBDC?

LBPH has a forward dividend yield of 3.33% ($2.00/share annually). GBDC yields 11.86% ($1.50/share annually). The yield gap is 8.53 percentage points.

Home › Compare › LBPH vs GBDC

LBPH vs GBDC: Dividend Comparison 2026

LBPH yields 3.33% · GBDC yields 11.86%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GBDC wins by $20.83M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LBPH

● Live price

3.33%

Share price

$59.98

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.8K

Annual income

$413.26

Full LBPH calculator →

GBDC

● Live price

11.86%

Share price

$12.65

Annual div

$1.50

5Y div CAGR

51.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.85M

Annual income

$16,450,733.83

Full GBDC calculator →

Portfolio growth — LBPH vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LBPH	GBDC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LBPH + GBDC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LBPH pays

GBDC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBPH

Annual income on $10K today (after 15% tax)

$283.43/yr

After 10yr DRIP, annual income (after tax)

$351.27/yr

GBDC

Annual income on $10K today (after 15% tax)

$1,007.91/yr

After 10yr DRIP, annual income (after tax)

$13,983,123.76/yr

At 15% tax rate, GBDC beats the other by $13,982,772.48/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBPH + GBDC for your $10,000?

LBPH: 50%GBDC: 50%

100% GBDC50/50100% LBPH

Portfolio after 10yr

$10.44M

Annual income

$8,225,573.55/yr

Blended yield

78.81%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

LBPH

No analyst data

GBDC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$14.00

+10.7% upside vs current

Range: $13.00 — $15.00

Altman Z

0.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBPH buys

GBDC buys

No recent congressional trades found for LBPH or GBDC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLBPHGBDC

Forward yield	3.33%	11.86% ✓
Annual dividend / share	$2.00 ✓	$1.50
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	51.1% ✓
Portfolio after 10y	$24.8K ✓	$20.85M
Annual income after 10y	$413.26	$16,450,733.83 ✓
Total dividends collected	$3.8K	$20.43M ✓
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: LBPH vs GBDC ($10,000, DRIP)

Year	LBPH Portfolio	LBPH Income/yr	GBDC Portfolio	GBDC Income/yr	Gap
1← crossover	$11,033	$333.44	$12,492	$1,791.70	$1.5K → GBDC
2	$12,150	$343.84	$16,527	$3,160.58	$4.4K → GBDC
3	$13,354	$353.85	$23,588	$5,904.90	$10.2K → GBDC
4	$14,652	$363.48	$37,141	$11,901.65	$22.5K → GBDC
5	$16,051	$372.73	$66,205	$26,463.38	$50.2K → GBDC
6	$17,556	$381.59	$137,452	$66,612.65	$119.9K → GBDC
7	$19,175	$390.07	$342,372	$195,298.53	$323.2K → GBDC
8	$20,915	$398.17	$1,053,292	$686,954.33	$1.03M → GBDC
9	$22,785	$405.89	$4,111,439	$2,984,416.95	$4.09M → GBDC
10	$24,793	$413.26	$20,849,974	$16,450,733.83	$20.83M → GBDC

LBPH vs GBDC: Complete Analysis 2026

LBPH — Stock

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Full LBPH Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →

📬

Get this LBPH vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBPH vs SCHD LBPH vs JEPI LBPH vs O LBPH vs KO LBPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.